Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.

Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR; CaPSURE Investigators.

J Urol. 2004 Apr;171(4):1393-401. Review.

PMID:
15017184
[PubMed - indexed for MEDLINE]
2.

Is there age bias in the treatment of localized prostate carcinoma?

Alibhai SM, Krahn MD, Cohen MM, Fleshner NE, Tomlinson GA, Naglie G.

Cancer. 2004 Jan 1;100(1):72-81.

PMID:
14692026
[PubMed - indexed for MEDLINE]
Free Article
3.

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR; CaPSURE.

J Urol. 2003 Dec;170(6 Pt 2):S21-5; discussion S26-7. Erratum in: J Urol. 2004 Feb;171(2 Pt 1):811.

PMID:
14610406
[PubMed - indexed for MEDLINE]
4.

Do older men benefit from curative therapy of localized prostate cancer?

Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD.

J Clin Oncol. 2003 Sep 1;21(17):3318-27.

PMID:
12947068
[PubMed - indexed for MEDLINE]
5.

Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS).

Roy DK, O'Neill TW, Finn JD, Lunt M, Silman AJ, Felsenberg D, Armbrecht G, Banzer D, Benevolenskaya LI, Bhalla A, Bruges Armas J, Cannata JB, Cooper C, Dequeker J, Diaz MN, Eastell R, Yershova OB, Felsch B, Gowin W, Havelka S, Hoszowski K, Ismail AA, Jajic I, Janott I, Johnell O, Kanis JA, Kragl G, Lopez Vaz A, Lorenc R, Lyritis G, Masaryk P, Matthis C, Miazgowski T, Gennari C, Pols HA, Poor G, Raspe HH, Reid DM, Reisinger W, Scheidt-Nave C, Stepan JJ, Todd CJ, Weber K, Woolf AD, Reeve J; European Prospective Osteoporosis Study (EPOS).

Osteoporos Int. 2003 Jan;14(1):19-26.

PMID:
12577181
[PubMed - indexed for MEDLINE]
6.

Cancer statistics, 2003.

Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ.

CA Cancer J Clin. 2003 Jan-Feb;53(1):5-26.

PMID:
12568441
[PubMed - indexed for MEDLINE]
7.

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.

J Urol. 2003 Feb;169(2):517-23.

PMID:
12544300
[PubMed - indexed for MEDLINE]
8.

Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.

Powell IJ, Tangen CM, Miller GJ, Lowe BA, Haas G, Carroll PR, Osswald MB, DeVERE WHITE R, Thompson IM Jr, Crawford ED.

J Urol. 2002 Nov;168(5):2016-9.

PMID:
12394698
[PubMed - indexed for MEDLINE]
9.

Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial.

Aus G, Abrahamsson PA, Ahlgren G, Hugosson J, Lundberg S, Schain M, Schelin S, Pedersen K.

BJU Int. 2002 Oct;90(6):561-6.

PMID:
12230618
[PubMed - indexed for MEDLINE]
10.

A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.

Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Häggman M, Andersson SO, Spångberg A, Busch C, Nordling S, Palmgren J, Adami HO, Johansson JE, Norlén BJ; Scandinavian Prostatic Cancer Group Study Number 4.

N Engl J Med. 2002 Sep 12;347(11):781-9.

PMID:
12226148
[PubMed - indexed for MEDLINE]
Free Article
11.

Critical evaluation of hormonal therapy for carcinoma of the prostate.

Chodak GW, Keane T, Klotz L; Hormone Therapy Study Group.

Urology. 2002 Aug;60(2):201-8. Review. No abstract available.

PMID:
12137810
[PubMed - indexed for MEDLINE]
12.

2001 American Urological Association Gallup Survey: changes in physician practice patterns, satisfaction with urology, and treatment of prostate cancer and erectile dysfunction.

O'Leary MP, Baum NH, Blizzard R, Blute ML, Cooper TP, Dineen MK, Fenninger RB, Gee WF, Gormley EA, Ignatoff JM, Nachtsheim DA, Painter MR, Thomas R, Wei JT; Health Policy Survey and Research Committee.

J Urol. 2002 Aug;168(2):649-52.

PMID:
12131336
[PubMed - indexed for MEDLINE]
13.

Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ.

J Natl Cancer Inst. 2002 Jul 3;94(13):981-90.

PMID:
12096083
[PubMed - indexed for MEDLINE]
Free Article
14.

Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?

Smith EB, Frierson HF Jr, Mills SE, Boyd JC, Theodorescu D.

Cancer. 2002 Apr 15;94(8):2282-7.

PMID:
12001128
[PubMed - indexed for MEDLINE]
15.

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

Choo R, Klotz L, Danjoux C, Morton GC, DeBoer G, Szumacher E, Fleshner N, Bunting P, Hruby G.

J Urol. 2002 Apr;167(4):1664-9.

PMID:
11912384
[PubMed - indexed for MEDLINE]
16.

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.

Carter HB, Walsh PC, Landis P, Epstein JI.

J Urol. 2002 Mar;167(3):1231-4.

PMID:
11832703
[PubMed - indexed for MEDLINE]
17.

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG.

J Clin Oncol. 2002 Jan 15;20(2):557-66.

PMID:
11786586
[PubMed - indexed for MEDLINE]
18.

Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.

Harlan LC, Potosky A, Gilliland FD, Hoffman R, Albertsen PC, Hamilton AS, Eley JW, Stanford JL, Stephenson RA.

J Natl Cancer Inst. 2001 Dec 19;93(24):1864-71.

PMID:
11752011
[PubMed - indexed for MEDLINE]
Free Article
19.

Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results.

Soloway MS, Pareek K, Sharifi R, Wajsman Z, McLeod D, Wood DP Jr, Puras-Baez A; Lupron Depot Neoadjuvant Prostate Cancer Study Group.

J Urol. 2002 Jan;167(1):112-6.

PMID:
11743286
[PubMed - indexed for MEDLINE]
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk